Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

1 min read

AGC Biologics’ $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

November 19, 2019 at 3:48 PM

Press Release

Read press release

1 min read

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

October 2, 2019 at 8:21 AM

Press Release

Read press release

2 min read

AGC Biologics Appoints New Chief Technical Officer

September 23, 2019 at 3:23 PM

Press Release

Read press release

1 min read

AGC Biologics Appoints New Site Head/General Manager of Bothell, WA Operations

September 23, 2019 at 3:12 PM

Press Release

Read press release

1 min read

U.S. Congresswoman, Suzan DelBene, Visits AGC Biologics Corporate Headquarters

May 2, 2019 at 7:27 AM

Press Release

Read press release

1 min read

Washington State Governor Jay Inslee Visits AGC Biologics Corporate Headquarters

March 28, 2019 at 2:42 PM

Press Release

Read press release

2 min read

AGC Biologics A/S and Calypso Biotech BV Announce Agreement for Process Development and cGMP Manufacture of CALY-002

February 19, 2019 at 3:31 PM

Press Release

Read press release

Prev 7 8 9 10 11

Our Company

Locations

Policies

Offerings

Services

Specialized Platforms & Programs

News & Blogs

Resources

Fact Sheet Quick Links

Join Us

What Drives Us

Meet Our Teams

Press Releases

AGC Biologics’ $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

AGC Biologics Appoints New Chief Technical Officer

AGC Biologics Appoints New Site Head/General Manager of Bothell, WA Operations

U.S. Congresswoman, Suzan DelBene, Visits AGC Biologics Corporate Headquarters

Washington State Governor Jay Inslee Visits AGC Biologics Corporate Headquarters

AGC Biologics A/S and Calypso Biotech BV Announce Agreement for Process Development and cGMP Manufacture of CALY-002

Our Mission

Links

News

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

Events

Advanced Therapies Week, January 20-23